Vonoprazan vs Lansoprazole for Healing and Maintenance of Healing of Erosive Esophagitis: A Randomized Trial

PHARMACODYNAMICS AND PHARMACOKINETICS OF THE POTASSIUM-COMPETITIVE ACID BLOCKER VONOPRAZAN AND THE PROTON PUMP INHIBITOR LANSOPRAZOLE IN U.S. SUBJECTS

(2022) Loren Laine et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease

(2021) Philip O. Katz et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2021

(2021) Anne F. Peery et al.   GASTROENTEROLOGY

Global Prevalence and Risk Factors of Gastro-oesophageal Reflux Disease (GORD): Systematic Review with Meta-analysis

(2020) Jorabar Singh Nirwan et al.   Scientific Reports

Phase III, randomised, double-blind, multicentre study to evaluate the efficacy and safety of vonoprazan compared with lansoprazole in Asian patients with erosive oesophagitis

(2019) Yinglian Xiao et al.   GUT

Maintenance for healed erosive esophagitis: Phase III comparison of vonoprazan with lansoprazole

(2018) Kiyoshi Ashida et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Esomeprazole and aspirin in Barrett's oesophagus (AspECT): a randomised factorial trial

(2018) Janusz A Z Jankowski et al.   LANCET

The binding selectivity of vonoprazan (TAK-438) to the gastric H+,K+-ATPase

(2015) D. R. Scott et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Randomised clinical trial: a dose-ranging study of vonoprazan, a novel potassium-competitive acid blocker, vs. lansoprazole for the treatment of erosive oesophagitis

(2015) K. Ashida et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Randomised clinical trial: vonoprazan, a novel potassium-competitive acid blocker, vs. lansoprazole for the healing of erosive oesophagitis

(2015) K. Ashida et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Systematic review: the effects of long-term proton pump inhibitor use on serum gastrin levels and gastric histology

(2015) L. Lundell et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Pharmacokinetics and Pharmacodynamics of the Proton Pump Inhibitors

(2013) Jai Moo Shin et al.   Journal of Neurogastroenterology and Motility

Clinical trial: dexlansoprazole MR, a proton pump inhibitor with dual delayed-release technology, effectively controls symptoms and prevents relapse in patients with healed erosive oesophagitis

(2009) D. C. METZ et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

No Association Between Gastric Fundic Gland Polyps and Gastrointestinal Neoplasia in a Study of Over 100,000 Patients

(2009) Robert M. Genta et al.   Clinical Gastroenterology and Hepatology